The GI Cancer Sessions: Highlights from ASCO GI 2022

In this episode of the VJOncology podcast, a panel of leading gastrointestinal (GI) cancer experts offer their perspectives on the key GI cancer data presented at the 2022 ASCO GI Cancers Symposium, held in San Francisco, CA, in January 2022. In this podcast, Nataliya Uboha, MD, PhD, University of Wisconsin, Madison, WI, is joined by Ghassan Abou-Alfa, MD, MBA, Memorial Sloan Kettering Cancer Center, New York, NY, and Kristen Ciombor, MD, MSci, Vanderbilt University Medical Center, Nashville, TN. Listen to learn about the latest clinical research and practice-changing advances in GI cancers, including the evaluation of durvalumab plus GemCis in biliary tract cancer in the TOPAZ-1 trial, how the HIMALAYA study compares to IMbrave150 in hepatocellular carcinoma and the assessment of adagrasib in KRAS G12C-mutated pancreatic ductal adenocarcinoma in KRYSTAL-1. In addition, the panel will be considering the implementation of circulating tumor DNA (ctDNA) testing in clinical practice for GI cancers following recent results from the CIRCULATE-Japan study, how the ACCENT IDEA study could change practice in stage III colorectal cancer, as well as advances in PD-1 blockade in MSI-high rectal cancer.